Welcome to our dedicated page for Alphatec Holdings news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Holdings stock.
Alphatec Holdings, Inc. (ATEC) is a leading medical technology company specializing in innovative spine surgery solutions. Our primary focus is the design, development, launch, and delivery of spinal fusion products aimed at improving patient outcomes. By collaborating with spine surgeons, we create and develop products and systems that address the entire spinal fusion procedure, enhancing efficiency and effectiveness.
At Alphatec Spine, we are committed to driving growth through constant innovation. Our product portfolio includes advanced technologies such as Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion. Each of these solutions is designed to simplify surgical procedures for surgeons, ultimately leading to superior patient outcomes.
We pride ourselves on our relentless pursuit of superior outcomes. By continuously developing technologies that positively impact patient care, we strive to be at the forefront of the medical technology industry. Our mission is to improve lives by providing cutting-edge spine surgery solutions.
For more detailed information about our products and ongoing projects, please visit our website at www.alphatecspine.com.
Latest News:
- --- Source: Alphatec Holdings, Inc.
- ---
- ---
- Source: Spineology Inc.
- ---
- ---
Alphatec Holdings, Inc. (ATEC) has announced the relocation to a new headquarters in Carlsbad, California, designed to enhance innovation and productivity. The 120,000 square-foot facility includes a seven-station cadaveric lab and advanced machining and biomechanical labs. The CEO emphasized that the facility is crucial for meeting training demands and fostering collaboration with surgeons. Currently employing around 300 people, ATEC plans to significantly increase its workforce in the coming years. This move is expected to support the company's growth and commitment to revolutionizing spine surgery.
Alphatec Holdings, Inc. (ATEC) reported strong preliminary revenue results for 2020 despite COVID-19 impacts. U.S. revenue for Q4 2020 surged by over 38% year-over-year, reaching approximately $43.0 million to $43.3 million, contributing to a full-year revenue of $141.0 million to $141.3 million, reflecting a growth of 30% to 31%. The company anticipates total revenue for 2021 to reach around $178 million, driven by continued product launches. However, future results may be influenced by ongoing pandemic effects on elective surgeries. Full financial results will be released on March 4, 2021.
Alphatec Holdings, Inc. (ATEC) announced that CFO Jeff Black will present at the H.C. Wainwright BioConnect 2021 Conference from January 11-14, 2021. The pre-recorded presentation will be available on demand for 90 days starting January 11 at 6 A.M. ET. Interested viewers can access it via this link. ATEC focuses on innovative spine surgery solutions and aims to become the standard bearer in the industry.
Alphatec Holdings, Inc. (ATEC) has announced its agreement to acquire EOS imaging, SA for $79.7 million plus $37.2 million in debt. This all-cash deal aims to enhance ATEC's clinical performance and revenue growth by integrating EOS' advanced imaging technology with its AlphaInformatiX platform. The acquisition is expected to expand ATEC's market penetration and accelerate global growth, providing immediate access to EOS' 380-unit installed base. The deal has been approved by both companies' boards and is predicted to be accretive to ATEC's revenue and free cash flow in its first year post-closure.
Alphatec Holdings, Inc. (ATEC) announced its participation in several upcoming investor conferences, including the Stifel Healthcare Conference on November 18, 2020, and the Canaccord Genuity Medical Technologies Forum on November 19, 2020. CEO Pat Miles and CFO Jeff Black will attend, engaging with registered investors. A live audio webcast of their presentations will be available on the company's Investor Relations page, with recordings accessible for 90 days. ATEC is dedicated to advancing spine surgery solutions through innovative medical devices and technology.
Alphatec Holdings (ATEC) reported a 43% year-over-year revenue growth, totaling $41.2 million for Q3 2020, marking the eighth consecutive quarter of double-digit growth. U.S. revenue reached $40.1 million, with a gross margin of 72.9%. The company successfully closed a follow-on offering generating $107.7 million to support growth initiatives. ATEC anticipates full-year 2020 revenue between $143.5 million and $146.0 million, with expected 25% growth in U.S. revenue for 2021, despite potential impacts from COVID-19.
Alphatec Holdings (ATEC) announced the launch of the InVictus™ MIS Tower system, enhancing minimally invasive spinal surgery options. This advanced fixation platform aims to treat complex pathologies with improved surgical adaptability. The InVictus Tower features innovative components such as low-profile removable towers and integrates with the SafeOp™ Neural InformatiX System for real-time nerve monitoring. CEO Pat Miles emphasized the commitment to developing solutions that enhance surgical outcomes, aiming for increased adoption and loyalty among surgeons.
Alphatec Holdings (ATEC) announced the closing of its public offering of 13,142,855 common shares, raising approximately $115 million at a price of $8.75 per share. This includes the full exercise of underwriters' options for an additional 1,714,285 shares. The offering was managed by Morgan Stanley and Cowen, among others. The shares were offered under a previously declared effective shelf registration statement with the SEC. ATEC aims to innovate spine surgery through its subsidiaries, focusing on safe and effective treatment solutions.
Alphatec Holdings, Inc. (ATEC) announced a public offering of 11,428,570 shares of its common stock priced at $8.75 per share, aiming for gross proceeds of approximately $100 million. The offering includes a 30-day option for underwriters to purchase an additional 1,714,285 shares. The transaction is expected to close on October 16, 2020, pending customary conditions. This offering is part of ATEC's strategy to enhance its capital for further innovative developments in spine surgery solutions.
Alphatec Holdings, Inc. (ATEC) has initiated an underwritten public offering of $85 million in common stock. Additionally, ATEC may grant underwriters a 30-day option to purchase up to 15% more shares. All shares are being sold by ATEC, and the offering is subject to market conditions. Morgan Stanley and Cowen are the joint book-running managers for this offering. The shares are offered under a shelf registration statement filed with the SEC. No assurance is provided regarding the completion or terms of the offering.
FAQ
What is the current stock price of Alphatec Holdings (ATEC)?
What is the market cap of Alphatec Holdings (ATEC)?
What does Alphatec Holdings, Inc. specialize in?
What are some of the key technologies developed by Alphatec Spine?
How does Alphatec Holdings, Inc. improve spine surgery procedures?
What is the mission of Alphatec Holdings, Inc.?
How does Alphatec Holdings, Inc. drive growth?
Where can I find more information about Alphatec Holdings, Inc.?
What recent achievements has Alphatec Holdings, Inc. made?
What are the main products of Alphatec Holdings, Inc.?
How does Alphatec Holdings, Inc. ensure superior patient outcomes?
Is Alphatec Holdings, Inc. involved in any partnerships?
